Resource overview
This study compares two real-time PCR-based rapid sterility testing kits for Advanced Therapy Medicinal Products (ATMPs): the Microsart® ATMP Sterile Release kit and an alternative solution. The importance of rapid sterility testing due to the short shelf life of ATMPs is underscored. The study evaluates the components, validation processes, and performance of both kits in detecting bacterial and fungal contamination. The workflow, sensitivity, and potential contamination risks associated with each kit are discussed.
The analysis highlights the Microsart® kit's advantages in reliability and user-friendliness, suggesting it as a more effective choice for ensuring the safety and quality of ATMPs in the pharmaceutical industry.
Key takeaways:
- The Microsart® kit integrates DNA extraction and PCR detection, unlike the alternative, which requires separate kits
- It offers a streamlined, user-friendly workflow, reducing complexity
- Demonstrates higher sensitivity and reliability in contamination detection
Resource details:
- Document type: Application Note
- Page count: 14
- Read time: 29 minutes
